Jaideep Dudani
Private Equity Investor bei Monograph Capital Advisors (UK) LLP
Profil
Jaideep Dudani is a Portfolio Principal at Monograph and leads Portfolio Development at Monograph’s portfolio company, Hi-Bio.
He was most recently at Relay Therapeutics, a precision medicine company focused on oncology and rare genetic diseases, where he played a cross-functional role in R&D and strategy and business development.
Before that, Jaideep was the first associate at Vida Ventures, and was involved in several of Vida’s investments, including Allogene Therapeutics (which held its initial public offering on the NASDAQ Global Select Market in 2018), Asklepios BioPharmaceutical (which was acquired by Bayer AG in 2020), Oyster Point Pharma (which held its initial public offering on the NASDAQ Global Select Market in 2019), and Pionyr Immunotherapeutics (which was acquired by Gilead Sciences, Inc. in 2020).
He completed his PhD at MIT in Biological Engineering, and holds a BS in Bioengineering from UCLA.
Aktive Positionen von Jaideep Dudani
Unternehmen | Position | Beginn |
---|---|---|
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Private Equity Investor | 01.07.2021 |
Ehemalige bekannte Positionen von Jaideep Dudani
Unternehmen | Position | Ende |
---|---|---|
RELAY THERAPEUTICS, INC. | Corporate Officer/Principal | 30.06.2021 |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Berater | 31.03.2018 |
Ausbildung von Jaideep Dudani
Massachusetts Institute of Technology | Doctorate Degree |
University of California, Los Angeles | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RELAY THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB. | Finance |
Glympse Bio, Inc.
Glympse Bio, Inc. BiotechnologyHealth Technology Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA. | Health Technology |